In The News

Startup medical sterilization equipment firm building $20M complex in North Sioux City

NORTH SIOUX CITY, May 16, 2021 — A medical-tech startup aims to have its headquarters and first production site up and running in North Sioux City by the end of this year.

And, if all goes well, the owner of NextBeam says more tech companies will flock to North Sioux just to be in their vicinity.

NextBeam, a medical equipment-sterilization business, is building a $20 million facility on the former Gateway campus, next to the Peru and Mexico buildings. NextBeam also will occupy some space in both Peru and Mexico, which was among the one-time black-and-white cow-spotted metal structures the computer maker built in the 1990s.

NextBeam is headed by tech veteran Andrew Patton, who served as a Google executive, an aerospace engineer with Boeing and a tech-investment banker in Silicon Valley before founding NextBeam last year.

The company was approved for $3 million in REDI (Revolving Economic and Development Initiative) loans by the South Dakota Board of Economic Development last year. Patton said the company will have 15 employees by the fourth quarter, later growing to more than 30.

READ MORE at the SIOUX CITY JOURNAL

Additional Articles We Think You Might Like

Have a question? Speak with a sterilization expert today, at your own convenience.

How EtO Litigation Will Impact The Future Of Medical Device Sterilization

November 2024 was an eventful month for Ethylene Oxide (EO) sterilizers: Cosmed announces bankruptcy filing – Reuters Steris discloses hundreds of ethylene oxide lawsuits over device...

Selecting the Right Sterility Assurance Level (SAL) for Medical Devices

Sterility is critical to ensuring the safety and efficacy of medical devices, particularly those intended for invasive use. The Sterility Assurance Level (SAL) represents the probability of a single...

What Possible FDA PFAS Restrictions Mean for Medical Device Manufacturers — and Future Sterilization Planning

The U.S. Food and Drug Administration (FDA) is increasingly scrutinizing the use of per- and polyfluoroalkyl substances (PFAS) in consumer products due to their potential health and environmental...